Corgenix Medical Corporation is based in metropolitan Denver, with its international marketing office near Cambridge, England. Corgenix is focused on the development and promotion of specialized diagnostic test kits for vascular diseases and immunological disorders. Corgenix diagnostic products are commercialized for use in clinical laboratories worldwide.

Statements that are not strictly historical are “forward- looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995, and should be considered as subject to various risks and uncertainties that could cause actual results to differ materially from those anticipated. Further risks are detailed in the Company's filings with the Securities and Exchange Commission, including those set forth in the Company's most recent Form 10-KSB and Quarterly Reports on Form 10-QSB.

Corporate Governance

Stock Information

News Releases